709 related articles for article (PubMed ID: 23279864)
1. Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agent.
Sun J; Zhu H; Yang ZM; Zhu HL
Eur J Med Chem; 2013 Feb; 60():23-8. PubMed ID: 23279864
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological evaluation, and molecular docking studies of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan moiety as potential anticancer agents.
Zhang XM; Qiu M; Sun J; Zhang YB; Yang YS; Wang XL; Tang JF; Zhu HL
Bioorg Med Chem; 2011 Nov; 19(21):6518-24. PubMed ID: 21962523
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors.
Zhang YB; Wang XL; Liu W; Yang YS; Tang JF; Zhu HL
Bioorg Med Chem; 2012 Nov; 20(21):6356-65. PubMed ID: 23018096
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, molecular modeling and biological evaluation of N-benzylidene-2-((5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl)thio)acetohydrazide derivatives as potential anticancer agents.
Zhang F; Wang XL; Shi J; Wang SF; Yin Y; Yang YS; Zhang WM; Zhu HL
Bioorg Med Chem; 2014 Jan; 22(1):468-77. PubMed ID: 24286761
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological evaluation, and molecular docking studies of 2-chloropyridine derivatives possessing 1,3,4-oxadiazole moiety as potential antitumor agents.
Zheng QZ; Zhang XM; Xu Y; Cheng K; Jiao QC; Zhu HL
Bioorg Med Chem; 2010 Nov; 18(22):7836-41. PubMed ID: 20947362
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of novel oxadiazole derivatives: a new class of thymidine phosphorylase inhibitors as potential anti-tumor agents.
Shahzad SA; Yar M; Bajda M; Jadoon B; Khan ZA; Naqvi SA; Shaikh AJ; Hayat K; Mahmmod A; Mahmood N; Filipek S
Bioorg Med Chem; 2014 Feb; 22(3):1008-15. PubMed ID: 24411198
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of N-phenylacetyl (sulfonyl) 4,5-dihydropyrazole derivatives as potential antitumor agents.
Liu XH; Ruan BF; Liu JX; Song BA; Jing LH; Li J; Yang Y; Zhu HL; Qi XB
Bioorg Med Chem Lett; 2011 May; 21(10):2916-20. PubMed ID: 21486698
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, biological evaluation, and molecular docking studies of N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)aniline derivatives as novel anticancer agents.
Huang XF; Lu X; Zhang Y; Song GQ; He QL; Li QS; Yang XH; Wei Y; Zhu HL
Bioorg Med Chem; 2012 Aug; 20(16):4895-900. PubMed ID: 22819191
[TBL] [Abstract][Full Text] [Related]
9. Novel 5-(2-hydroxyphenyl)-3-substituted-2,3-dihydro-1,3,4-oxadiazole-2-thione derivatives: promising anticancer agents.
Aboraia AS; Abdel-Rahman HM; Mahfouz NM; El-Gendy MA
Bioorg Med Chem; 2006 Feb; 14(4):1236-46. PubMed ID: 16242340
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, biological evaluation, and molecular docking studies of novel 1,3,4-oxadiazole derivatives possessing benzotriazole moiety as FAK inhibitors with anticancer activity.
Zhang S; Luo Y; He LQ; Liu ZJ; Jiang AQ; Yang YH; Zhu HL
Bioorg Med Chem; 2013 Jul; 21(13):3723-9. PubMed ID: 23673215
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, molecular modeling and biological evaluation of 2-(benzylthio)-5-aryloxadiazole derivatives as anti-tumor agents.
Liu K; Lu X; Zhang HJ; Sun J; Zhu HL
Eur J Med Chem; 2012 Jan; 47(1):473-8. PubMed ID: 22119130
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and pharmacological evaluation of novel substituted quinoline-2-carboxamide derivatives as human dihydroorotate dehydrogenase (hDHODH) inhibitors and anticancer agents.
Vyas VK; Variya B; Ghate MD
Eur J Med Chem; 2014 Jul; 82():385-93. PubMed ID: 24929289
[TBL] [Abstract][Full Text] [Related]
13. Structure-based design, synthesis and evaluation of novel anthra[1,2-d]imidazole-6,11-dione derivatives as telomerase inhibitors and potential for cancer polypharmacology.
Chen CL; Chang DM; Chen TC; Lee CC; Hsieh HH; Huang FC; Huang KF; Guh JH; Lin JJ; Huang HS
Eur J Med Chem; 2013 Feb; 60():29-41. PubMed ID: 23279865
[TBL] [Abstract][Full Text] [Related]
14. Novel 3-(2-(3-methyl-5-substituted-phenyl-4,5-dihydropyrazol-1-yl)-2-oxoethoxy)-2-substituted-phenyl-4H-chromen-4-one: synthesis and anticancer activity.
Liu XH; Li J; Wu FR; Song BA; Bhadury PS; Shi L
Med Chem; 2011 Nov; 7(6):605-10. PubMed ID: 22313300
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, thymidine phosphorylase inhibitory and computational study of novel 1,3,4-oxadiazole-2-thione derivatives as potential anticancer agents.
Bajaj S; Roy PP; Singh J
Comput Biol Chem; 2018 Oct; 76():151-160. PubMed ID: 30015176
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro anticancer activity of 6,7-methylenedioxy (or 5-hydroxy-6-methoxy)-2-(substituted selenophenyl)quinolin-4-one analogs.
Chen CT; Hsu MH; Cheng YY; Liu CY; Chou LC; Huang LJ; Wu TS; Yang X; Lee KH; Kuo SC
Eur J Med Chem; 2011 Dec; 46(12):6046-56. PubMed ID: 22030314
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and in vitro anticancer activity of novel quinoline and oxadiazole derivatives of ursolic acid.
Gu W; Jin XY; Li DD; Wang SF; Tao XB; Chen H
Bioorg Med Chem Lett; 2017 Sep; 27(17):4128-4132. PubMed ID: 28733083
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and anticancer activities of novel 3,5-disubstituted-1,2,4-oxadiazoles.
Kumar D; Patel G; Johnson EO; Shah K
Bioorg Med Chem Lett; 2009 May; 19(10):2739-41. PubMed ID: 19376704
[TBL] [Abstract][Full Text] [Related]
19. New 2-benzylsulfanyl-nicotinic acid based 1,3,4-oxadiazoles: their synthesis and biological evaluation.
Patel NB; Purohit AC; Rajani DP; Moo-Puc R; Rivera G
Eur J Med Chem; 2013 Apr; 62():677-87. PubMed ID: 23434641
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro antiproliferative effect of novel quinoline-based potential anticancer agents.
Arafa RK; Hegazy GH; Piazza GA; Abadi AH
Eur J Med Chem; 2013 May; 63():826-32. PubMed ID: 23584545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]